rs144237457

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016343.4(CENPF):​c.3617A>G​(p.Tyr1206Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00319 in 1,595,864 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 10 hom. )

Consequence

CENPF
NM_016343.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 0.175

Publications

8 publications found
Variant links:
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
CENPF Gene-Disease associations (from GenCC):
  • Stromme syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003427714).
BP6
Variant 1-214641955-A-G is Benign according to our data. Variant chr1-214641955-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 434704.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00218 (332/152326) while in subpopulation AMR AF = 0.00333 (51/15300). AF 95% confidence interval is 0.00272. There are 0 homozygotes in GnomAd4. There are 137 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPFNM_016343.4 linkc.3617A>G p.Tyr1206Cys missense_variant Exon 12 of 20 ENST00000366955.8 NP_057427.3
CENPFXM_017000086.3 linkc.3617A>G p.Tyr1206Cys missense_variant Exon 12 of 20 XP_016855575.1
CENPFXM_011509082.4 linkc.3617A>G p.Tyr1206Cys missense_variant Exon 12 of 19 XP_011507384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPFENST00000366955.8 linkc.3617A>G p.Tyr1206Cys missense_variant Exon 12 of 20 1 NM_016343.4 ENSP00000355922.3
CENPFENST00000706765.1 linkc.3617A>G p.Tyr1206Cys missense_variant Exon 12 of 19 ENSP00000516538.1

Frequencies

GnomAD3 genomes
AF:
0.00218
AC:
332
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00306
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00255
AC:
589
AN:
231036
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.000530
Gnomad AMR exome
AF:
0.000995
Gnomad ASJ exome
AF:
0.00831
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00210
Gnomad NFE exome
AF:
0.00372
Gnomad OTH exome
AF:
0.00399
GnomAD4 exome
AF:
0.00329
AC:
4753
AN:
1443538
Hom.:
10
Cov.:
35
AF XY:
0.00321
AC XY:
2304
AN XY:
717586
show subpopulations
African (AFR)
AF:
0.000436
AC:
14
AN:
32092
American (AMR)
AF:
0.00136
AC:
54
AN:
39804
Ashkenazi Jewish (ASJ)
AF:
0.00777
AC:
195
AN:
25094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39630
South Asian (SAS)
AF:
0.000757
AC:
62
AN:
81898
European-Finnish (FIN)
AF:
0.00236
AC:
125
AN:
52898
Middle Eastern (MID)
AF:
0.00195
AC:
11
AN:
5652
European-Non Finnish (NFE)
AF:
0.00370
AC:
4094
AN:
1106990
Other (OTH)
AF:
0.00333
AC:
198
AN:
59480
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
248
496
743
991
1239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00218
AC:
332
AN:
152326
Hom.:
0
Cov.:
33
AF XY:
0.00184
AC XY:
137
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41576
American (AMR)
AF:
0.00333
AC:
51
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00306
AC:
208
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00311
Hom.:
11
Bravo
AF:
0.00235
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00263
AC:
319

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
May 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Nov 29, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stromme syndrome Uncertain:1
Sep 27, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
5.3
DANN
Benign
0.80
DEOGEN2
Benign
0.023
T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-0.95
T
PhyloP100
0.17
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.015
Sift
Benign
0.15
T
Sift4G
Benign
0.19
T
Polyphen
0.13
B
Vest4
0.26
MVP
0.36
MPC
0.067
ClinPred
0.0019
T
GERP RS
1.7
Varity_R
0.075
gMVP
0.22
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144237457; hg19: chr1-214815298; COSMIC: COSV108211087; API